These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 25209550)
1. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. Kyeyune R; Saathoff E; Ezeamama AE; Löscher T; Fawzi W; Guwatudde D BMC Infect Dis; 2014 Sep; 14():496. PubMed ID: 25209550 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia. Gebreweld A; Fiseha T; Girma N; Haileslasie H; Gebretsadik D PLoS One; 2020; 15(9):e0239215. PubMed ID: 32931523 [TBL] [Abstract][Full Text] [Related]
3. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study. Gunda DW; Godfrey KG; Kilonzo SB; Mpondo BC Malawi Med J; 2017 Mar; 29(1):43-52. PubMed ID: 28567196 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Predictors of Cytopenias in HIV-Infected Adults at Initiation of Antiretroviral Therapy in Mehal Meda Hospital, Central Ethiopia. Fiseha T; Ebrahim H J Blood Med; 2022; 13():201-211. PubMed ID: 35502291 [TBL] [Abstract][Full Text] [Related]
5. Magnitude and associated factors of cytopenias among antiretroviral therapy naïve Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia. Tamir Z; Seid A; Haileslassie H PLoS One; 2019; 14(2):e0211708. PubMed ID: 30759131 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and Risk Factors of Cytopenia in HIV-Infected Patients before and after the Initiation of HAART. Fan L; Li C; Zhao H Biomed Res Int; 2020; 2020():3132589. PubMed ID: 32090076 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study. Usman A; Balogun O; Shuaib BI; Musa BOP; Yusuf AA; Ajayi EIO Infect Chemother; 2023 Dec; 55(4):479-489. PubMed ID: 38183393 [TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting. Kalyesubula R; Kagimu M; Opio KC; Kiguba R; Semitala CF; Schlech WF; Katabira ET Afr Health Sci; 2011 Mar; 11(1):16-23. PubMed ID: 21572852 [TBL] [Abstract][Full Text] [Related]
9. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study. McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741 [TBL] [Abstract][Full Text] [Related]
10. Impaired Hematologic Status in Relation to Clinical Outcomes among HIV-Infected Adults from Uganda: A Prospective Cohort Study. Ezeamama AE; Guwatudde D; Sikorskii A; Kabagambe EK; Spelts R; Vahey G; Fenton JI; Fawzi WW Nutrients; 2018 Apr; 10(4):. PubMed ID: 29649107 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART. Owiredu WK; Quaye L; Amidu N; Addai-Mensah O Afr Health Sci; 2011 Mar; 11(1):2-15. PubMed ID: 21572851 [TBL] [Abstract][Full Text] [Related]
12. Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia. Mengist HM; Taye B; Tsegaye A PLoS One; 2015; 10(2):e0117715. PubMed ID: 25658626 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Mildvan D; Creagh T; Leitz G; Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689 [TBL] [Abstract][Full Text] [Related]
14. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ; Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda. Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164 [TBL] [Abstract][Full Text] [Related]
16. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda. Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients. Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298 [TBL] [Abstract][Full Text] [Related]
18. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study. Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338 [TBL] [Abstract][Full Text] [Related]
19. Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors. Kiguba R; Byakika-Tusiime J; Karamagi C; Ssali F; Mugyenyi P; Katabira E J Acquir Immune Defic Syndr; 2007 Jun; 45(2):218-23. PubMed ID: 17438478 [TBL] [Abstract][Full Text] [Related]
20. Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda. Masaisa F; Gahutu JB; Mukiibi J; Delanghe J; Philippé J Am J Trop Med Hyg; 2011 Mar; 84(3):456-60. PubMed ID: 21363986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]